Page 151 - MI-2-3
P. 151

Microbes & Immunity                                                   Characterizing low-grade CNS tumors



            13.  Zheng Y, Graeber MB. Microglia and brain macrophages   Rural Pract. 2016;7(4):510-514.
               as drivers of glioma progression.  Int J Mol Sci.      doi: 10.4103/0976-3147.188626
               2022;23(24):15612.
                                                               24.  Akyurek S, Chang EL, Yu TK, et al. Spinal myxopapillary
               doi: 10.3390/ijms232415612
                                                                  ependymoma outcomes in patients treated with surgery and
            14.  Vidyarthi A, Agnihotri T, Khan N, et al. Predominance of   radiotherapy at M.D. Anderson cancer center. J Neurooncol.
               M2 macrophages in gliomas leads to the suppression of   2006;80(2):177-183.
               local and systemic immunity. Cancer Immunol Immunother.   doi: 10.1007/s11060-006-9169-2.
               2019;68(12):1995-2004.
                                                               25.  Snuderl M, Chi SN, De Santis SM, et al. Prognostic value
               doi: 10.1007/s00262-019-02423-8
                                                                  of tumor microinvasion and metalloproteinases expression
            15.  Rajendran  G,  Shanmuganandam  K,  Bendre  A,    in intracranial pediatric ependymomas. J Neuropathol Exp
               Muzumdar  D, Goel A, Shiras A. Epigenetic regulation   Neurol. 2008;67(9):911-920.
               of DNA methyltransferases: DNMT1 and DNMT3B in      doi: 10.1097/NEN.0b013e318184f413
               gliomas. J Neurooncol. 2011;104(2):483-494.
                                                               26.  Chen  X,  Li  C,  Che  X,  Chen  H,  Liu  Z. Spinal
               doi: 10.1007/s11060-010-0520-2
                                                                  myxopapillary ependymomas: A  retrospective clinical
            16.  Zhao Y, Gan L, Ren L, Lin Y, Ma C, Lin X. Factors   and immunohistochemical study.  Acta Neurochir (Wien).
               influencing the blood-brain barrier permeability. Brain Res.   2016;158(1):101-107.
               2022;1788:147937.
                                                                  doi: 10.1007/s00701-015-2637-8
               doi: 10.1016/j.brainres.2022.147937
                                                               27.  Ghosh K, Ghosh S, Chatterjee U, Chaudhuri S, Anirban A.
            17.  Alanen KA, Joensuu H, Klemi PJ. DNA ploidy and cell-  Microglial contribution to glioma progression: An
               cycle analysis in pancreatic and ampullary carcinoma: Flow   immunohistochemical study in Eastern India. Asian Pac J
               cytometric study of formalin-fixed paraffin-embedded tissue.   Cancer Prev. 2016;17(6):2767-2773.
               Virchows Arch A Pathol Anat Histopathol. 1991;419(3):255-256.
                                                               28.  Sato K, Kuratsu J, Takeshima H, Yoshimura T, Ushio Y.
               doi: 10.1007/BF01626357                            Expression  of  monocyte  chemoattractant  protein-1  in
                                                                  meningioma. J Neurosurg. 1995;82(5):874-878.
            18.  Bready D, Placantonakis DG. Molecular pathogenesis of
               low-grade glioma. Neurosurg Clin N Am. 2019;30(1):17-25.     doi: 10.3171/jns.1995.82.5.0874
               doi: 10.1016/j.nec.2018.08.011                  29.  Lochhead JJ, Yang J, Ronaldson PT, Davis TP. Structure,
                                                                  function, and regulation of the blood-brain barrier tight
            19.  Yrysov K, Arstanbekov N, Mamytov M, Akmataliev A,
               Turganbaev  B, Vityala Y. Postoperative complications  in   junction in central nervous system disorders. Front Physiol.
               patients with intracranial meningiomas who underwent   2020;11:914.
               surgery. Biomedicine. 2023;43(3):34-40.            doi: 10.3389/fphys.2020.00914
               doi: 10.51248/.v43i3.2886                       30.  Yan D, Kowal J, Akkari L,  et al. Inhibition of colony
                                                                  stimulating factor-1 receptor abrogates microenvironment-
            20.  Chang JH, Chang JW, Choi JY, Park YG, Chung SS.
               Complications after gamma knife radiosurgery for   mediated therapeutic resistance in gliomas.  Oncogene.
               benign meningiomas.  J  Neurol Neurosurg Psychiatry.   2017;36(43):6049-6058.
               2003;74(2):226-230.                                doi: 10.1038/onc.2017.261
               doi: 10.1136/jnnp.74.2.226                      31.  Kvisten M, Mikkelsen VE, Stensjøen AL, Solheim O, Van
                                                                  Der Want J, Torp SH. Microglia and macrophages in human
            21.  Bertrand KC, Klimo P. Recent advancements in
               ependymoma: Challenges and therapeutic opportunities.   glioblastomas: A morphological and immunohistochemical
               Pediatr Neurosurg. 2023;58(5):307-312.             study. Mol Clin Oncol. 2019;11(1):31-36.
                                                                  doi: 10.3892/mco.2019.1856
               doi: 10.1159/000530868
                                                               32.  Gutmann DH, Kettenmann H. Microglia/brain macrophages
            22.  Thotakura M, Tirumalasetti N, Krishna R. Role of Ki-67
               labeling index as an adjunct to the histopathological   as central drivers of brain tumor pathobiology.  Neuron.
               diagnosis and grading of astrocytomas. J Cancer Res Ther.   2019;104(3):442-449.
               2014;10(3):641-645.                                doi: 10.1016/j.neuron.2019.08.028
               doi: 10.4103/0973-1482.139154                   33.  Dubuc AM, Mack S, Unterberger  A, Northcott PA,
                                                                  Taylor MD. The epigenetics of brain tumors. Methods Mol
            23.  Shivaprasad NV, Satish S, Ravishankar S, Vimalambike MG.
               Ki-67  immunostaining  in  astrocytomas:  Association  with   Biol. 2012;863:139-153.
               histopathological grade - a South Indian study. J Neurosci      doi: 10.1007/978-1-61779-612-8_8


            Volume 2 Issue 3 (2025)                        143                           doi: 10.36922/MI025190040
   146   147   148   149   150   151   152   153   154   155   156